Two ternary copper(ll) complexes of indomethacin [1-(4-chlorobenzoyl)-5-methoxy-2-methyl-l-H-indole-3-acetic acid] called hereafter Indo, were prepared and characterized by single crystal X-ray diffraction. The first complex Co u2(Indo)4(DMF) crystallizes in space group P-1 (a 10.829(2), b 13.379 (2) 
Introduction
Alzheimer's disease (AD), the third most costly disease after cancer and heart diseases [1] , is a neurodegenerative disorder, the primary or neuropathogenic mechanism of which is unknown. This disease is characterized by abnormal accumulation of amyloid peptide (1 A4) from its precursor amyloid precursor protein. Mutations in the gene encoding amyloid precursor on chromosome 21 have been found to segregate with AD [2] . The inflammatory hypothesis of Alzheimer' s disease is based on the observation that individuals susceptible to the disease and who are undergoing treatment for a known inflammatory injury will be inadvertently treating their latent AD and will therefore have a reduced risk of developing a clinical case [3] [4] . It was hypothesized that antiinflammatory drugs such as NSAIDs may slow the onset or progression of AD by reducing inflammation in brain due to the deposition of amyloid protein and consequent damage to brain cells. Activated microglia are found to be present in AD [5] and associated with the generation of components of the classical complement pathway, demonstrating the onset of an inflammatory process. Moreover, some of these components stimulate the respiratory burst system of the microglia, resulting in the production of toxic reactive oxygen species such as superoxide anion, Ternary Copper(II) Complexes with Indomethacin, A Potent Non-Steroidal Anti-Inflammatory Drug hydrogen peroxide and hydroxyl radical [5] . Current clues to possible treatment include the potential use of antioxidants, oestrogens, antiinflammatory drugs or compounds altering amyloid metabolism. Strategy in addressing the stimulation of the immune system has been effective in reducing AD progression in clinical trials related to the cyclooxygenase inhibitor indomethacin [6] , which rapidly and efficiently penetrates the blood-brain barrier. While aspirin [7] , ibuprofen [8] and indomethacin [9] are at best only very weak free radical scavengers in vitro systems, their copper complexes are very efficient free radical scavengers [10] ; these drugs are thus expected to circumvent the toxicity of reactive oxygen species generated in the activated microglia. Even if NSAIDs prove to confer a protective benefit against inflammatory brain disorders, their use is often associated with a broad spectrum of untoward reactions, particularly in the gastrointestinal tract which may constitute a limiting factor for their continuous administration [11] . Copper [12, 13] . Further, a recent investigation of copper(ll) complex equilibria (under physiological conditions) with salicylic or acetylsalicylic acids has shown that their anions may favour the gastrointestinal absorption of copper(ll) [14] . In previous work, Sorenson described the synthesis of many copper(ll)-NSAIDs complexes and among them, Cu-indomethacin complex [12, 13] . (2) ,&, [15, [22] [23] (21) 0(22) Cu is 89.9(2) in I. In conclusion, the crystal structures of is essentially the same as in III except for the DMF or DMSO accomodation. However, compare to the molecular structure of the indomethacin free ligand [24] , there is a conformation change in the second indomethacinate ligand as shown by the 0(3) C (13) An inflammatory process has been demonstrated by a significant enhancement of MPO activity in intestinal tissue after administration of NSAIDs ( Figure 2 ). This enzyme released by inflammation cells and particularly polymorphonuclear cells is generally considered as a good marker of inflammatory process and classically measured to appreciate such a phenomenon. Since myeloperoxidase-mimetic activity has been reported with some copper complexes [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] (1) 2.629 (2) O (22) [12, 27] . In a previous study, we showed that high doses of copper indomethacinate exerted a slight protective effect on the gastrointestinal tract [16] . This effect seems to be due to free radical scavenging properties more than to a modulation of NOS activity and was strongly potentiated by drug encapsulation. Gastrointestinal inflammation which is the worse side effect of NSAID administration can be decreased by copper complexes and moreover by encapsulation in liposomes or nanocapsules [16] . This (8 min per exposure) were obtained with 0 < q) < 250 and with the crystals oscillated through 1.5 in Coverage of the unique set was over 95% complete to at least 20.8 The structures were solved by direct methods (SIR92) [29] and refined by least-squares procedures on F. For both the compounds, the DMF ligand is severely disordered. It appears on two forms, having the O and N atoms in common. The occupancy factors for the C atoms are in the ratio 0.54(2)/0.46(2)/in I. All these disorders were treated using a fully constrained refinement (site occupancies, coordinates, thermal parameters) with the help of the SHELXL-97 program [30] . The H atoms were introduced as riding model. They were given isotropic thermal parameters 20% higher than those of the carbon to which they are attached.
Least-squares refinements were carried out by minimising the function T_.W(Fo--Fc), where F o and F c are the observed and calculated structure factors. The weighting scheme used in the last refinement cycles was w=1/[2 (Fo2)+(XP)] where P=(Fo+2Fc)/3 and X= 0.1448 for I. Details of data collection and refinement are given in Table 3 .
Calculations were performed with the SHELXL-97 programs [30] running on a PC. The drawing of the molecule was obtained using CAMERON [31] . Jejuno-ileum ulceration was round, segmental and sometimes confluent. Damage was scored by tracing the outline of ulcerated areas from two-fold magnified photographic images onto paper, and massing the cut-outs. Jejuno-ileum damage score (expressed in %) was expressed as the ratio: sum of ulcerated areas/total photographed area x'100 [32] . 3.4.3 . NOS activities in tissue samples.
Tissue iNOS activity was estimated by measuring the conversion of L-4C-arginine to L-4C-citrulline as described by Bush et al. [33] . Tissue [35] : concentration was determined in duplicate spectrophotometrically using the Griess reagent (1% sulfanimide, 0.1% naphthylenediamine dihydrochloride, and 2.5% H3PO4) [36] . Final 
